Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Hepatobiliary, Pancreatic and Intestinal Diseases Research Institute of North Sichuan Medical College, Nanchong, China.
Ann Surg Oncol. 2023 Mar;30(3):1366-1378. doi: 10.1245/s10434-022-12647-1. Epub 2022 Oct 22.
The aim of this study was to compare the short- and long-term outcomes of laparoscopic surgery (LS) and open surgery (OP) for perihilar cholangiocarcinoma (PHC) using a large real-world dataset in China.
Data of patients with PHC who underwent LS and OP from January 2013 to October 2018, across 10 centers in China, were extracted from medical records. A comparative analysis was performed before and after propensity score matching (PSM) in the LS and OP groups and within the study subgroups. The Cox proportional hazards mixed-effects model was applied to estimate the risk factors for mortality, with center and year of operation as random effects.
A total of 467 patients with PHC were included, of whom 161 underwent LS and 306 underwent OP. Postoperative morbidity, such as hemorrhage, biliary fistula, abdominal abscess, and hepatic insufficiency, was similar between the LS and OP groups. The median overall survival (OS) was longer in the LS group than in the OP group (NA vs. 22 months; hazard ratio [HR] 1.19, 95% confidence interval [CI] 1.02-1.39, p = 0.024). Among the matched datasets, OS was comparable between the LS and OP groups (NA vs. 35 months; HR 0.99, 95% CI 0.77-1.26, p = 0.915). The mixed-effect model identified that the surgical method was not associated with long-term outcomes and that LS and OP provided similar oncological outcomes.
Considering the comparable long-term prognosis and short-term outcomes of LS and OP, LS could be a technically feasible surgical method for PHC patients with all Bismuth-Corlett types of PHC.
本研究旨在使用中国的大型真实世界数据集比较腹腔镜手术(LS)和开腹手术(OP)治疗肝门部胆管癌(PHC)的短期和长期结果。
从中国 10 家中心的病历中提取了 2013 年 1 月至 2018 年 10 月期间接受 LS 和 OP 的 PHC 患者的数据。在 LS 和 OP 组进行倾向评分匹配(PSM)前后以及在研究亚组内进行了对比分析。应用 Cox 比例风险混合效应模型估计死亡率的危险因素,以中心和手术年份为随机效应。
共纳入 467 例 PHC 患者,其中 161 例行 LS,306 例行 OP。LS 和 OP 组术后并发症(如出血、胆瘘、腹腔脓肿和肝功能不全)相似。LS 组的中位总生存期(OS)长于 OP 组(无进展生存期(NA) vs. 22 个月;风险比 [HR] 1.19,95%置信区间 [CI] 1.02-1.39,p=0.024)。在匹配数据集,LS 和 OP 组的 OS 无差异(NA vs. 35 个月;HR 0.99,95%CI 0.77-1.26,p=0.915)。混合效应模型确定手术方法与长期结果无关,LS 和 OP 提供了相似的肿瘤学结果。
考虑到 LS 和 OP 的短期结果和长期预后相当,LS 可为所有 Bismuth-Corlett 型 PHC 患者提供一种可行的手术方法。